NanoSyrinx co-founder Nick Waterfield appointed as Professor at Warwick Medical School

The whole NanoSyrinx team would like to congratulate our co-founder Nick Waterfield on his recently announced promotion to full Professor at the University of Warwick Medical School.

This is a richly deserved appointment as Prof. Waterfield’s track record in molecular microbiology is substantial. With particular emphasis on bacterial toxicology and the adaptations required for benign environmental bacteria to become hazardous to human health, the Waterfield lab is well known in the field.

Without his fascination and deep insights about bacterial evolution, the types of innovative discoveries that underpin NanoSyrinx’s core technology would not have happened.

Congratulations Nick!

Read more news

NanoSyrinx in Parliament

Our Founder and CEO, Joe Healey, was invited by the Parliamentary and Scientific Committee (P&SC – to discuss the future and potential of Synthetic Biology for the UK and for human health. The UK has a stated (and laudable) ambition to become a “Scientific Superpower”, and Synthetic Biology is intimately tied to that vision. […]

Read more

NanoSyrinx featured by Spin-up Science on YouTube

Ben Miles at Spin-up Science took time recently to feature NanoSyrinx in their latest YouTube video. Follow the links below to learn how what NanoSyrinx is developing could, in Ben’s words, “change medicine forever”. You can also hear more from the discussion on the Scientist-to-CEO podcast Ben runs, which is available here: Spin up Science […]

Read more

NanoSyrinx named as winner of the 2022 AbbVie UK Golden Ticket programme

NanoSyrinx has been named as the winner of the 2022 AbbVie UK Golden Ticket accelerator programme. The 2022 AbbVie UK Golden Ticket is a competitive award, open to early-stage life sciences companies and biotech start-ups that are working to develop cutting-edge therapies or technology platforms. Under the programme, the company will benefit from: One year […]

Read more